Would the cost-cutting measures for U.S. prescription drugs proposed by the Trump administration on Monday hurt the biotech ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.

The evolving needs of Indian pharma industry encompass advanced skills in areas like biologics, AI, and automation ...

A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...

President Donald Trump put the biopharma industry on its back foot earlier this month with his executive order on ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

We hoped industry layoffs would relent in ... Story Feb. 6 - X4 Pharmaceuticals: The rare disease biotech is laying off 43 employees—equivalent to 30% of the company’s total staffers—along ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on ...